Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS3 | P29474 | 2/20 | 0.41 |
| ▸ | NOS1 | P29475 | 2/20 | 0.41 |
| ▸ | NOS2 | P35228 | 2/20 | 0.41 |
| ▸ | GRM5 | P41594 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 4/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | PI4KA | P42356 | 1/20 | 0.41 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.41 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.41 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetaldehyde SCHEMBL27271887 | 0.88 | GRM5 (0.42) | NOS3NOS1NOS2GRM5NPC1 | |
| SCHEMBL28151639 | 0.86 | GRM5 (0.41) | NOS3NOS1NOS2GRM5NPC1 | |
| Formic Acid SCHEMBL27263940 | 0.86 | ALDH1A1 (0.43) | NOS3NOS1NOS2GRM5NPC1 | |
| Hydrazine SCHEMBL27879593 | 0.85 | — | — | |
| Methylamine SCHEMBL11641782 | 0.85 | — | — | |
| SCHEMBL29599136 | 0.85 | KDM4E (0.50) | NOS3NOS1NOS2GRM5NPC1 | |
| SCHEMBL4733426 | 0.85 | KDM4E (0.50) | NOS3NOS1NOS2GRM5NPC1 | |
| SCHEMBL2684 | 0.85 | — | — | |
| SCHEMBL29472848 | 0.85 | — | — | |
| SCHEMBL16322907 | 0.85 | KDM4E (0.50) | NOS3NOS1NOS2GRM5NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110520127-A | Piperidinyl-substituted and piperazinyl-substituted heteroaromatic carboxamides as modulators of GPR6 | TAKEDA PHARMACEUTICALS CO | 2019-11-29 | — | — | CN | disclosed |
| CN-110357888-A | Heterocycle phosphodiesterase inhibitors and application thereof | 南京药捷安康生物科技有限公司 | 2019-10-22 | — | — | CN | disclosed |
| CN-110072526-A | Kinase inhibitor compounds, compositions and methods for treating cancer | 西奈山伊坎医学院 | 2019-07-30 | — | — | CN | disclosed |
| CN-109096250-A | 4- phenoxypyridines class compound and its application containing pyridazinone | 辽宁大学 | 2018-12-28 | — | — | CN | disclosed |
| CN-108430503-A | Compositions and methods for activating 'interferon gene stimulator' dependent signaling | 艾杜罗生物科技公司 | 2018-08-21 | — | — | CN | disclosed |
| CN-105153026-B | Sorafenib derivative of the amide structure containing biaryl and its preparation method and application | 江西科技师范大学 | 2018-02-02 | — | — | CN | disclosed |
| CN-107530415-A | For activating the composition and method of the conduction of \" interferon gene stimulant \" dependent signals | 艾杜罗生物科技公司 | 2018-01-02 | — | — | CN | disclosed |
| CN-107129465-A | Aryl guanidine compound and its production and use | 中国科学院上海药物研究所 | 2017-09-05 | — | — | CN | disclosed |
| CN-107106561-A | Heparan sulfate biosynthesis inhibitor for treating disease | 生物马林药物股份有限公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-104496896-B | The preparation and application of the Sorafenib derivative of the urea structure containing sulphonyl | 江西科技师范大学 | 2017-07-14 | — | — | CN | disclosed |
| CN-101432281-B | 6-0-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling | NOVARTIS AG | 2013-08-28 | — | — | CN | disclosed |
| CN-101432281-A | 6-O-substituted benzoxazole and benzothiazole compounds and methods for inhibiting CSF-1R signaling | NOVARTIS AG (CH) | 2009-05-13 | — | — | CN | disclosed |